Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Director departure
CALYPTE BIOMEDICAL CORP (CBMC) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2014 8-K Quarterly results
03/18/2014 8-K Material Modifications to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statemen...
Docs: "Certificate of Amendment of Restated Certificate of Incorporation"
01/15/2014 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Investment Agreement between the Registrant and the Purchaser"
01/03/2013 8-K Form 8-K - Current report
04/30/2012 8-K Form 8-K - Current report
10/14/2011 8-K Form 8-K - Current report
07/09/2010 8-K Form 8-K - Current report
02/09/2010 8-K Form 8-K - Current report
09/25/2009 8-K Form 8-K - Current report
09/16/2009 8-K Form 8-K - Current report
03/19/2009 8-K Form 8-K - Current report
02/27/2009 8-K Form 8-K -- Current report
01/09/2009 8-K Form 8-K -- Current report
12/16/2008 8-K Form 8-K -- Current report
11/25/2008 8-K Form 8-K -- Current report
09/23/2008 8-K Form 8-K -- Current report
09/05/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
08/21/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "8",
"8"
06/18/2008 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "Calypte Biomedical Appoints Donald Taylor as CEO Sales-focused Executive Takes Leadership; Roger Gale Remains Chairman; Existing Investors to Exercise $1 Million of Warrants"
04/17/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Prepared Remarks of Roger I. Gale and Ronald W. Mink for Calypte Biomedical Corporation Analyst/Investor Conference Call held on April 17, 2008",
"Calypte’s Aware™ HIV-1/2 OMT Approved as China's Only Rapid Oral HIV Test"
01/23/2008 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "COMMON STOCK PURCHASE AGREEMENT",
"REGISTRATION RIGHTS AGREEMENT",
"Calypte Biomedical Enters Into $8.0 Million Common Stock Purchase Agreement with Fusion Capital"
12/13/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Prepared Remarks of Roger I. Gale for Calypte Biomedical Corporation Annual Meeting of Stockholders held on December 6, 2007 and stockholder questions and Company responses thereto"
12/10/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "3",
"3"
11/26/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
09/18/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Prepared Remarks of Roger I. Gale and Ronald W. Mink for Calypte Biomedical Corporation Analyst/Investor Conference Call held on September 18, 2007"
05/21/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Prepared Remarks of Roger I. Gale, Richard D. Brounstein and Jerrold D. Dotson for Calypte Biomedical Corporation First Quarter 2007 Analyst/Investor Conference Call held on May 18, 2007"
05/14/2007 8-K Appointed a new director
Docs: "Calypte Appoints New Board Member"
04/06/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Prepared Remarks of Roger I. Gale, Richard D. Brounstein and Jerrold D. Dotson for Calypte Biomedical Corporation Fourth Quarter 2006 Analyst/Investor Conference Call held on April 5, 2007"
02/06/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
01/19/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/18/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Calypte Announces Results of 2006 Annual Stockholders’ Meeting CEO Comments on Progress Toward Chinese SFDA Approval"
11/20/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Prepared Remarks of Roger I. Gale and Theodore R. Gwin for Calypte Biomedical Corporation Third Quarter 2006 Analyst/Investor Conference Call held on November 15, 2006"
09/08/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "Calypte Receives Approval to Commence Trading on the OTCBB"
08/15/2006 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Prepared Remarks of Roger I. Gale and Theodore R. Gwin Calypte Biomedical Corporation Second Quarter 2006"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy